■ Effectiveness of royal jelly supplementation in glycemic regulation: a systematic review
Kamel Omer, Maxwell J Gelkopf, Genevieve Newton
World J Diabetes. 2019 Feb 15; 10(2): 96–113
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379731/
■ Effect of kiwifruit on metabolic health in patients with cardiovascular risk factors: a systematic review and meta-analysis
Naeti Suksomboon, Nalinee Poolsup, Wei Lin
Diabetes Metab Syndr Obes. 2019; 12: 171–18
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350646/
■ Psychosocial interventions for reducing diabetes distress in vulnerable people with type 2 diabetes mellitus: a systematic review and meta-analysis
Anne Sophie Mathiesen, Ingrid Egerod, Tonny Jensen et a
Diabetes Metab Syndr Obes. 2019; 12: 19–3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301434/
■ Canagliflozin review – safety and efficacy profile in patients with T2DM
Haroon Jakher, Tara I Chang, Marilyn Tan, Kenneth W Mahaffey
Diabetes Metab Syndr Obes. 2019; 12: 209–215
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363491/
■ Association between sarcopenic obesity and highter risk of type 2 diabetes in adults: a systematic review and meta-analysis
Dima Khadra, Leila Itani, Hana Tannir et al
World J Diabetes. 2019, vol 10(5): 311–323
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522758/
■ Effect of diabetic ketoacidosis in the respiratory system
Alice Gallo de Moraes, Salim Surani
World J Diabetes. 2019 Jan 15; 10(1): 16–2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347653/
■ Evaluating all potential oral complications of diabetes mellitus
Martijn J. L. Verhulst, Bruno G. Loos, Victor E. A. Gerdes, Wijnand J. Teeu
Front Endocrinol (Lausanne) 2019; 10: 56
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439528/
■ Candida sp. Infections in patients with diabetes mellitus
Célia F. Rodrigues, Maria Elisa Rodrigues, Mariana Henriques
J Clin Med. 2019 Jan; 8(1): 76
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352194/
■ Type 2 diabetes mellitus: outpatient insulin management
A Howard-Thompson, M Khan, M Jones, C M George
Am Fam Physician 2018, vol 97(1): 29-37
https://www.aafp.org/afp/2018/0101/p29.html
■ The role of glucagon in the pathophysiology and treatment of type 2 diabetes
S Haedersdal, A Lund, P K Knop, T Wilsbell
Mayo Clinic Proceedings 2018, vol 93 (2):217-239
https://www.mayoclinicproceedings.org/article/S0025-6196(17)30874-1/fulltext
■ Diabetes mellitus and its cardiovascular complication: new insights into an old disease
C Sardu, C de Lucia, M Wallner, G Santulli
Journal of Diabetes Research 2019, Article ID 1905194, 2 pages
https://www.hindawi.com/journals/jdr/2019/1905194/
■ Cardiovascular autonomic neuropathy in type 2 diabetic patients.
Breder, Ikaro Soares Santos and Sposito, Andrei C.
Rev. Assoc. Med. Bras., Jan 2019, vol.65, no.1, p.56-60
■ Diabetic cardiomyopathy: factual or factoid?.
Quinaglia, Thiago et al
Rev. Assoc. Med. Bras., Jan 2019, vol.65, no.1, p.61-6
■ Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: current evidence
Leonardo Pozo, Fatimah Bello, Andres Suarez et al
World J Diabetes. 2019 May 15; 10(5): 291–303
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522760/
■ Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trial
Deborah Hinnen, Davida F Kruger
Diabetes Metab Syndr Obes. 2019; 12: 447–455
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452802/
■ Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date
Rebecca Howell, Adrienne M Wright, Jennifer N Clements
Diabetes Metab Syndr Obes. 2019; 12: 505–512
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475096/
■ Evolving spectrum of diabetic nephropathy
Jonathan Kopel, Camilo Pena-Hernandez, Kenneth Nugent
World J Diabetes. 2019 May 15; 10(5): 269–279
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522757/
■ Management of diabetic dyslipidemia: an update
Ishwarlal Jialal, Gurdeep Singh
World J Diabetes. 2019 May 15; 10(5): 280–290
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522756/
■ Diabetes in childhood and adolescent: a guideline-based approach to diagnosis treatment, and follow-up
H Zulewski, L Giovanella, S Bilz et al
Dtsch Arztebl Int 2018, vol115 (9); 146-156
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876549/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Novo endereço:
Consultório: Rua Padre Rolim 815/sala 815
Tel: 33245518 (Consulta Particular/Unimed)
– Centro Médico Unimed BH/Contagem/Pedro I
Belo Horizonte/MG/Brasil
CRMMG: 7026
Email: pfleite1873@gmail.com